COMPOSITION

  • Glimepiride IP 1 mg
  • Metformin Hydrohloride 500 mg
  • ( As Sustained Ralease Form )

PRODUCT DESCRIPTION

Cinque Terre

Introduction

Epiride M1 Tablet contains glimepiride and metformin in sustainrelease form.

Glimepiride is a sulfonylurea anti-diabetic drug. It belongs to third generation anti-diabetic drug.

Metformin

It is also an oral antidiabetic drug which belongs to biguanide class which is the first line treatment for type 2 diabetes mellitus. It causes suppression of glucose production by liver. 

 

Indication

  • First line treatment for type 2 diabetes
  • Metformin is used in pre-diabetes
  • PCOS (polycystic ovary syndrome)
  • Gastrointestinal diabetes

 

 

Dosage

As directed by the physician

 

Mechanism of action

Glimepiride

It causes the stimulation of insulin release from pancreatic β-cells which causes the inhibition of gluconeogenesis in hepatic cells. This also increases the insulin sensitivity.

 Metformin

It decreases gluconeogenesis in liver and also decreases the intestinal absorption of glucose. It also improves the sensitivity of insulin. 

Pharmacology

Metformin

Absorption

In fasting condition of the patients, the drug bioavailability is about 50% to 60%. Food decreases the absorption of drug.

Distribution

The volume of distribution is 654±358 L. It rarely bonds to plasma protein. It does not follow hepatic metabolism.

Excretion

It is excreted in unchanged form in urine

 

Glimepiride 

Absorption

The drug is well absorbed with peak drug concentration attaining in 2 to 3hrs. When drug is administered with food the concentration maximum was decreased by 8%

Distribution

The drug is well distributed in the body and volume of distribution is 8.8 L. the drug is metabolized by oxidative biotransformation. In the biotransformation of glimepiride to M1, cytochrome P450 2C9 is involved. The major metabolites are the cyclohexyl hydroxy methyl derivative (M1) and the carboxyl derivative (M2).

Excretion

About 60% of the drug is excreted through urine in seven days.   

 

Contraindications

  • Use is contraindicated in pregnant patient
  • In lactating mothers
  • Renal dysfunction
  • Patient undergoing radiological studies
  • Acute or chronic metabolic acidosis

 

 

 

 

Precautions

  • Renal and hepatic impairment
  • Avoid alcohol consumption
  • Hypoglycemic episodes
  • Lung and liver disease

 


Cinque Terre